Skip to content

Opening book details…

About this Medicine article

OP0046 Tofacitinib, an Oral Janus Kinase Inhibitor, in a Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy in a Phase 3 Randomised Clinical Trial by Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J.
Publisher
BMJ Publishing Group; BMJ (ISSN 0003-4967)
Published
2013
Language
EN
Field
Medicine (Health Sciences)

More by Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J.

Browse all works by Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J.